Brussels, 12/04/2006 (Agence Europe) - The European Commission has approved the planned acquisition by US healthcare group Boston Scientific Corporation of its competitor Guidant Corporation, a US company specialised in cardiovascular medical products, subject to conditions. In parallel, the Commission has also cleared the acquisition of Guidant's interventional cardiology and endovascular devices businesses by Abbott Laboratories (“Abbott”), also subject to commitments. Boston...